FindMyKOL
Clinical trialNCT00036452CompletedPhase 2Interventional

A Study to Compare Anti-HIV Drugs Given Twice a Day or Once a Day, With or Without Direct Observation

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment402HIV Infections
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Anti-HIV drug therapy works best when the drugs are taken exactly as prescribed by a doctor. Because anti-HIV therapy often involves multiple drugs, some people have difficulty taking them all correctly. The easier it is to take anti-HIV drugs, the more likely people will take them as prescribed and get the best results. This study will see if people are more successful in taking anti-HIV drugs once a day or twice a day. It also will determine if having a health care professional oversee each weekday dose helps people control their HIV infection. The study will compare taking a three-drug combination twice a day versus taking a three-drug combination just once a day. The study will also compare patients taking the drugs on their own to patients taking the drugs in the presence of a clinical worker. Viral load (amount of HIV in the blood) and drug side effects will be measured.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

29 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Puerto Rico
  • Puerto Rico-Aids Crs

    San Juan, Puerto Rico

South Africa
  • Wits Hiv Crs

    Johannesburg, Gauteng, South Africa

United States
  • Usc Crs

    Los Angeles, California, United States

  • Univ. of California Davis Med. Ctr., Actu

    Sacramento, California, United States

  • Ucsd, Avrc Crs

    San Diego, California, United States

  • University of Colorado Hospital Crs

    Aurora, Colorado, United States

  • Univ. of Miami Aids Crs

    Miami, Florida, United States

  • Univ. of Hawaii at Manoa, Leahi Hosp.

    Honolulu, Hawaii, United States

  • Indiana Univ. School of Medicine, Infectious Disease Research Clinic

    Indianapolis, Indiana, United States

  • Ihv Baltimore Treatment Crs

    Baltimore, Maryland, United States

  • Johns Hopkins Adult Aids Crs

    Baltimore, Maryland, United States

  • Sstar, Family Healthcare Ctr.

    Fall River, Massachusetts, United States

  • University of Minnesota, Actu

    Minneapolis, Minnesota, United States

  • Beth Israel Med. Ctr., Actu

    New York, New York, United States

  • Ny Univ. Hiv/aids Crs

    New York, New York, United States

  • Aids Care Crs

    Rochester, New York, United States

  • Mccree Mcculler Wellness Ctr. at the Connection, Infectious Disease Unit

    Rochester, New York, United States

  • Univ. of Rochester Actg Crs

    Rochester, New York, United States

  • Unc Aids Crs

    Chapel Hill, North Carolina, United States

  • Regional Center for Infectious Disease, Wendover Medical Center Crs

    Greensboro, North Carolina, United States

  • Wake County Health and Human Services Crs

    Raleigh, North Carolina, United States

  • Univ. of Cincinnati Crs

    Cincinnati, Ohio, United States

  • Metrohealth Crs

    Cleveland, Ohio, United States

  • the Ohio State Univ. Aids Crs

    Columbus, Ohio, United States

  • Hosp. of the Univ. of Pennsylvania Crs

    Philadelphia, Pennsylvania, United States

  • Pitt Crs

    Pittsburgh, Pennsylvania, United States

  • the Miriam Hosp. Actg Crs

    Providence, Rhode Island, United States

  • Vanderbilt Therapeutics Crs

    Nashville, Tennessee, United States

  • University of Washington Aids Crs

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
—
Primary completion
—
Completion
31 Jan 2006
Last update posted
1 Nov 2021
Registered enrollment
402
Registry id
NCT00036452

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.